A method for verification of treatment times for high-dose-rate intraluminal brachytherapy treatment
Purpose: This study was aimed to increase the quality of high dose rate (HDR) intraluminal brachytherapy treatment. For this purpose, an easy, fast and accurate patient-specific quality assurance (QA) tool has been developed. This tool has been implemented at Bahawalpur Institute of Nuclear Medicine and Oncology (BINO), Bahawalpur, Pakistan.
Methods: ABACUS 3.1 Treatment planning system (TPS) has been used for treatment planning and calculation of total dwell time and then results were compared with the time calculated using the proposed method. This method has been used to verify the total dwell time for different rectum applicators for relevant treatment lengths (2-7 cm) and depths (1.5-2.5 cm), different oesophagus applicators of relevant treatment lengths (6-10 cm) and depths (0.9 & 1.0 cm), and a bronchus applicator for relevant treatment lengths (4-7.5 cm) and depth (0.5 cm).
Results: The average percentage differences between treatment time TM with manual calculation and as calculated by the TPS is 0.32% (standard deviation 1.32%) for rectum, 0.24% (standard deviation 2.36%) for oesophagus and 1.96% (standard deviation 0.55%) for bronchus, respectively. These results advocate that the proposed method is valuable for independent verification of patient-specific treatment planning QA.
Conclusion: The technique illustrated in the current study is an easy, simple, quick and useful for independent verification of the total dwell time for HDR intraluminal brachytherapy. Our method is able to identify human error-related planning mistakes and to evaluate the quality of treatment planning. It enhances the quality of brachytherapy treatment and reliability of the system.
Lindel K. Interventional radiotherapy or brachytherapy: new challenges for a successful technique. 2nd Annual Conference of Bangladesh Medical Physics Society. Int J Cancer Ther Oncol. 2013;1(1).
Lanciano RM, Martz K, Coia LR, Hanks GE. Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys. 1991;20(1):95-100.
Montana GS, Wesley CF, Varia MA, et al. Carcinoma of the Cervix, Stage III, Results of radiation therapy. Cancer 1986; 57: 148-54.
Halperin EC, Brady LW, Perez CA, Wazer DE. Perez & Brady's Principles and Practice of Radiation Oncology, Chapter 25, 6th Edition. Lippincott Williams & Wilkins: 2013.
Thomadsen B, Lin SW, Laemmrich P, et al. Analysis of treatment delivery errors in brachytherapy using formal risk analysis techniques. Int J Radiat Oncol Biol Phys. 2003;57:1492-508.
Towards Safer Radiotherapy. British Institute of Radiology. Institute of Physics and Engineering in Medicine, National Patient Safety Agency, Society and College of Radiographers. The Royal College of Radiologists, London, 2007.
Kubo HD, Glasgow GP, Pethel TD, et al. High dose-rate brachytherapy treatment delivery: report of the AAPM Radiation Therapy Committee Task Group No. 59. Medical physics. 1998; 25(4): 375-403.
Quino LV, Huerta-Hernandez C, Papanikolaou N, et al. A Monte Carlo model for independent dose verification in IMRT and VMAT for the Varian Novalis TX with high definition MLC. Int J Cancer Ther Oncol. 2015;3(3):3312.
Kubo H. Verification of treatment plans by mathematical formulas for single catheter HDR brachytherapy. Med Dosim. 1992;17(3):151-5.
Rogus RD, Smith MJ, Kubo HD. An equation to QA check the total treatment time for single-catheter HDR brachytherapy. Int J Radiat Oncol Biol Phys. 1998;40(1):245-8.
Mayo CS, Ulin K. A method for checking high dose rate treatment times for vaginal applicators. J Appl Clin Med Phys. 2001;2(4):184-90.
Buzdar SA, Gadhi MA, Rao MA, et al. Verification of computerized treatment planning for HDR 192Ir brachytherapy for gynaecological cancer. J Pak Med Assoc. 2009;59(2):113-5.
Miller AV, Davis MG, Horton JL. A method for verifying treatment times for simple high-dose-rate endobronchial brachytherapy procedures. Med Phys. 1996;23(11):1903-8.
Ezzell GA. A manual algorithm for computing dwell times for two-catheter endobronchial treatments using HDR brachytherapy. Med Phys. 2000;27(5):1030-3.
Thomadsen BR, Shahabi S, Stitt JA, et al. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerations. Int J Radiat Oncol Biol Phys. 1992;24(2):349-57.
Das RK, Bradley KA, Nelson IA, et al. Quality assurance of treatment plans for interstitial and intracavitary high-dose-rate brachytherapy. Brachytherapy. 2006; 5(1):56-60.
Murrer L, Kolkman-Deurloo IK. Manual calculation of treatment time for high dose rate brachytherapy with a flexible intraoperative template (FIT). Phys Med Biol. 2001;46(4):1075-84.
Huckle A, Al-Qaisieh B, Bownes P. Methods of verifying the output of the treatment planning system used for high dose rate (HDR) prostate brachytherapy. Radiother Oncol. 2012;103(2):261-5.
Ezzell GA. Quality assurance of treatment plans for optimized high dose rate brachytherapy--planar implants. Med Phys. 1994;21(5):659-61.
Venselaar JL, Bierhuizen HW, Klop R. A method to check treatment time calculations in Ir-192 high-dose-rate volume implants. Med Phys. 1995;22(9):1499-500.
Hadad K, Ganapol BD, Hamilton R, Watchman C. Dose verification for accelerated partial breast irradiation. International Conference on Advances in Mathematics, Computational Methods & Reactor Physics; Saratoga Springs, NY; 2009.
Kumar R, Sharma SD, Vijaykumar C, et al. A dose verification method for high-dose-rate brachytherapy treatment plans. J Cancer Res Ther. 2008;4(4):173-7.
Lachaine ME, Gorman JC, Palisca MG. A fast, independent dose check of HDR plans. J Appl Clin Med Phys. 2003;4(2):149-55.
Cohen GN, Amols HI, Zaider M. An independent dose-to-point calculation program for the verification of high-dose-rate brachytherapy treatment planning. Int J Radiat Oncol Biol Phys. 2000;48(4):1251-8.
Johns HE, Cunningham JR. Physics of radiology, 4th Edition Chapter 13, 1983.
This work is licensed under a Creative Commons Attribution 3.0 License.
International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)
© International Journal of Cancer Therapy and Oncology (IJCTO)
To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.